GC Content

GC Content

🧬 What Is GC Content?

GC content refers to the percentage of guanine (G) and cytosine (C) bases in a DNA molecule—calculated as (G + C)/(A + T + G + C) × 100% pubmed.ncbi.nlm.nih.gov+15pmc.ncbi.nlm.nih.gov+15blog.genewiz.com+15.

AAV inverted terminal repeats (ITRs) are naturally GC-rich (~65–70%) and form stable palindromic hairpins pmc.ncbi.nlm.nih.gov+15pmc.ncbi.nlm.nih.gov+15genscript.com+15.

image

Figure 1: Visualizing GC Content for a sequence

⚙ Role & Impact in AAV Manufacturing

1. ITR Stability & Plasmid Integrity

2. Sequencing Difficulties

3. Impact on Analytical QC

🧩 GC Optimization Strategies

Challenge
Impact
Strategy
ITR instability
Reduced packaging, yield variability
Screen clones rigorously; use low-stress bacterial strains; confirm integrity before productiontandfonline.com+4insights.bio+4criver.com+4
Sequencing dropouts
Poor QC read coverage
Use PCR additives, long-read sequencing, or PCR-free methods
Quantification biases
Inaccurate titer estimation
Design primers outside GC-rich regions and validate qPCR/ddPCR accuracy
Immunogenic CpG motifs
Potential innate activation
Engineer CpG-depleted ITRs while preserving GC content for structural integrity

🧪 Early Workflow Integration

The accompanying schematic indicates the earliest stage in AAV production where GC content considerations start:

  1. Transfer plasmid design: ITRs flank the transgene cassette, forming GC-rich hairpins (as shown above)criver.com+15mdpi.com+15pmc.ncbi.nlm.nih.gov+15.
  2. Bacterial amplification: High-GC ITRs may induce deletions during propagation.
  3. Screen & QC: Early sequencing or restriction screening is critical before entering cell culture/factory to maintain integrity.

✅ Summary & Best Practices

  • Monitor GC-rich ITRs meticulously during plasmid cloning for deletions.
  • Use sequencing strategies optimized for GC—e.g., PCR additives, PCR-free, or third-gen sequencing.
  • Validate titration assays against GC bias to ensure accurate dosage metrics.
  • Implement CpG-engineering as part of structural optimization to improve immunogenicity profiles.

Managing GC content effectively—in particular within AAV ITRs—is crucial for robust plasmid integrity, reliable QC, proper titration, and overall manufacturing consistency.